Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou can take Wegovy at any time of day — morning, afternoon or evening — because semaglutide's once-weekly dosing means the exact hour matters far less than keeping to the same day each week. There is no clinical evidence that taking semaglutide at night produces better or worse weight-loss results. What does matter is consistency, tolerability, and finding a routine you can stick to. Like all prescription-only weight-management medicines, Wegovy requires a clinical assessment before it can be prescribed; a prescriber decides whether it is appropriate for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A common assumption is that GLP-1 medicines behave like tablets that depend on circadian rhythms, and that injecting at the 'wrong' time could undermine the treatment. This comes from a reasonable instinct (many medicines do have time-sensitive dosing windows) but it doesn't apply here. Semaglutide has a half-life of approximately one week, which is why the licensed schedule is once-weekly rather than once-daily. That long half-life means blood levels stay broadly stable across a seven-day period; a six-hour shift in injection time from one week to the next has no meaningful effect on how the medicine behaves.
The NHS patient information for semaglutide confirms that you may inject Wegovy at any time of day and do not need to take it with food or water. The instruction to keep to the same day each week is there precisely because the seven-day interval is what maintains steady drug exposure, the clock time is secondary. If you miss a day entirely, the guidance is to inject as soon as you remember, provided your next scheduled dose is at least two days away; for anything less certain than that, the Patient Information Leaflet and your prescriber are the right source of advice.
So if you have been worrying that an evening injection is somehow less effective than a morning one, you can set that concern aside.
Nausea is the most commonly reported side effect of semaglutide, particularly in the hours after a new injection or a dose increase. It tends to peak within the first day and then ease. For people who find that window uncomfortable, injecting in the evening means most of that peak discomfort falls during sleep rather than during a working day or a family meal. This is a practical comfort strategy rather than a clinical recommendation, but it is a legitimate reason to choose a night-time schedule, and our guide to taking Wegovy at night explains the reasoning and practicalities in more detail.
Other people prefer morning injections precisely because they want to be awake and alert if any symptoms feel unusual, particularly when starting treatment or stepping up to a new dose. Both approaches are reasonable. There is no evidence that one protects against side effects more than the other; the choice is about what fits your life and your comfort level.
A question our prescribers hear regularly is whether changing the time of injection mid-treatment causes problems. The short answer is no, as long as you are not changing the day of the week at the same time. If you want to shift from, say, Sunday mornings to Sunday evenings, that is a small adjustment that does not affect your dosing interval.
The things that do matter are the weekly interval, proper injection technique, rotating your injection sites (abdomen, thigh or upper arm), and storing the pen correctly in the fridge between uses. Site rotation reduces the risk of skin reactions at any single spot. The full Wegovy treatment guide covers storage and technique in detail, and if you are using a vial and syringe rather than a pre-filled pen, our step-by-step page on how to dilute semaglutide safely walks you through the process, always follow that rather than any figure you find online.
If you are considering moving your Wegovy injection to the evening, the main practical thing to think about is making sure you have the pen accessible and properly refrigerated wherever you are. Travelling, overnight stays and late shifts can all affect routine, plan those weeks in advance rather than improvising.
There are also situations where timing becomes a more nuanced question. Women using oral contraceptives alongside tirzepatide have specific guidance about pill absorption, but semaglutide does not carry the same concern. If you are on other medications and wondering about spacing injections alongside them, that is a conversation for your prescribing clinician rather than a general rule. You can explore weight-management treatment options at nume, where every new prescription and every repeat is reviewed individually by a GPhC-registered prescriber, the same day, on a clinical basis, never by an automated process.
For a broader look at the evidence behind timing preferences, this page examines whether night-time really is the better option and what the clinical literature does and doesn't say. And if you are weighing up the cost and practicalities of treatment, the weight-loss treatment overview gives honest context on what private prescription covers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.